◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › 0-9 › 2290

Lung Fung Group Holdings Limited (2290) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Consumer Cyclical · Department Stores · DATA UPDATED 2026-09-22

Lung Fung Group Holdings Limited (2290) operates in the Department Stores industry and is headquartered in Fanling, Hong Kong with about 837 employees. Its market capitalization is roughly HK$2 billion. In the fiscal year ended 2025-03-31, 2290 reported HK$2.5B in revenue and HK$170M in net income.

Lung Fung Group Holdings Limited, through its subsidiaries, sells beauty, health and pharmaceutical products. The company offers Chinese and western medicines, health products, medical supplies, beauty and skin care, cosmetics, maternal and infant products, food, and personal care, and household daily necessities.

Interactive charts & full statements → Open the 2290 valuation workbench →

2290 Revenue & Earnings History — Annual Income Statement

Income statement2025-03-312024-03-312023-03-31
Total RevenueHK$2.5BHK$2.0BHK$1.1B
Gross ProfitHK$778MHK$593MHK$272M
Operating Income (EBIT)HK$317MHK$243MHK$13M
Net IncomeHK$170MHK$144M(HK$27M)

HKD; HK$M / HK$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

2290 Free Cash Flow History

2290 Balance Sheet History

Balance sheet2025-03-312024-03-312023-03-31
Total AssetsHK$1.3BHK$1.3BHK$1.2B
Total LiabilitiesHK$1.2BHK$1.2BHK$1.2B

HKD; HK$M / HK$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 2290 viewer.

Other Companies in Department Stores

← 2289All “0-9” companies2291 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.